sponsored
PatientsVille.com Logo

PatientsVille

Azithromycin and Simvastatin

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectAzithromycinSimvastatin
PAIN3.3% 1.9%
DYSPNOEA3.2% 2.9%
NAUSEA3.2% 2.8%
FATIGUE1.9% 2.9%
DIARRHOEA2.7% 2.5%
DRUG INEFFECTIVE1.9% 2.7%
VOMITING2.5% 1.8%
DIZZINESS1.8% 2.5%
PNEUMONIA2.3% 1.4%
ANXIETY2.2% 0.9%
FALL0.9% 2.1%
ASTHENIA1.6% 2%
PYREXIA2% 1%
INJURY2% 0%
HEADACHE1.8% 1.9%
DRUG INTERACTION1.6% 1.9%
MYALGIA0.5% 1.9%
MALAISE1.4% 1.8%
COUGH1.8% 1.1%
PULMONARY EMBOLISM1.8% 0%
PAIN IN EXTREMITY1% 1.7%
ABDOMINAL PAIN1.6% 0.9%
ARTHRALGIA0.9% 1.6%
RASH1.5% 1.2%
DRUG HYPERSENSITIVITY1.4% 0.5%
DEEP VEIN THROMBOSIS1.4% 0%
CHEST PAIN1.3% 1.2%
WEIGHT DECREASED1.2% 1.3%
RHABDOMYOLYSIS0% 1.3%
HYPOTENSION1.2% 1.2%
ANAEMIA1.2% 1.1%
DEPRESSION1.2% 1%
PRURITUS1% 1.2%
INSOMNIA0.9% 1.2%
ABDOMINAL PAIN UPPER1.2% 0.8%
CONFUSIONAL STATE0.6% 1.2%
EMOTIONAL DISTRESS1.2% 0%
RENAL FAILURE ACUTE1.1% 1%
DEATH0.9% 1.1%
OFF LABEL USE0.6% 1.1%
GAIT DISTURBANCE0.6% 1.1%
BACK PAIN0.9% 1%
HYPERTENSION0.8% 1%
DECREASED APPETITE0.8% 1%
MUSCLE SPASMS0.6% 1%
MYOCARDIAL INFARCTION0.5% 1%
MUSCULAR WEAKNESS0% 1%
GASTROINTESTINAL HAEMORRHAGE0% 1%
BLOOD GLUCOSE INCREASED0% 1%
ACUTE KIDNEY INJURY0% 1%
HAEMORRHAGE1% 0%
OEDEMA PERIPHERAL0.9% 0.9%
DEHYDRATION0.8% 0.9%
CONDITION AGGRAVATED0.9% 0.8%
RENAL FAILURE0.7% 0.9%
CONSTIPATION0.7% 0.9%
FEELING ABNORMAL0.6% 0.9%
CEREBROVASCULAR ACCIDENT0.5% 0.9%
HYPERSENSITIVITY0.9% 0.5%
CHOLECYSTITIS CHRONIC0.9% 0%
FLUSHING0% 0.9%
SYNCOPE0.7% 0.8%
ATRIAL FIBRILLATION0.7% 0.8%
GENERAL PHYSICAL HEALTH DETERIORATION0.8% 0.6%
PARAESTHESIA0.5% 0.8%
URINARY TRACT INFECTION0.5% 0.8%
PALPITATIONS0.8% 0.5%
SOMNOLENCE0% 0.8%
DRUG DOSE OMISSION0% 0.8%
RESPIRATORY FAILURE0.8% 0%
TREMOR0.7% 0.7%
HYPOAESTHESIA0.6% 0.7%
WEIGHT INCREASED0.5% 0.7%
LOSS OF CONSCIOUSNESS0.5% 0.7%
HYPERHIDROSIS0.5% 0.7%
THROMBOCYTOPENIA0.7% 0.4%
URTICARIA0.7% 0%
BRONCHITIS0.7% 0%
CHOLELITHIASIS0.7% 0%
BLOOD PRESSURE INCREASED0% 0.7%
CARDIAC FAILURE CONGESTIVE0.6% 0.6%
SEPSIS0.6% 0.6%
ERYTHEMA0.6% 0.6%
ABDOMINAL DISCOMFORT0.5% 0.6%
INTERNATIONAL NORMALISED RATIO INCREASED0.6% 0.4%
DYSPHAGIA0.6% 0.4%
ALOPECIA0% 0.6%
BALANCE DISORDER0% 0.6%
BLOOD CREATINE PHOSPHOKINASE INCREASED0% 0.6%
INJECTION SITE PAIN0% 0.6%
HAEMOGLOBIN DECREASED0% 0.6%
MEMORY IMPAIRMENT0% 0.6%
GALLBLADDER DISORDER0.6% 0%
ABORTION INCOMPLETE0.6% 0%
SINUSITIS0.6% 0%
ECONOMIC PROBLEM0.6% 0%
TACHYCARDIA0.6% 0%
CHEST DISCOMFORT0.6% 0%
ASTHMA0.6% 0%
DYSPEPSIA0.5% 0.5%
NASOPHARYNGITIS0.5% 0.5%
BLOOD CREATININE INCREASED0.4% 0.5%
RENAL IMPAIRMENT0% 0.5%
PERIPHERAL SWELLING0% 0.5%
CONTUSION0% 0.5%
PRODUCT QUALITY ISSUE0% 0.5%
HYPONATRAEMIA0% 0.5%
VISION BLURRED0% 0.5%
HYPOGLYCAEMIA0% 0.5%
EPISTAXIS0% 0.5%
DIABETES MELLITUS0% 0.5%
TOXICITY TO VARIOUS AGENTS0.5% 0%
INFECTION0.5% 0%
CHILLS0.5% 0%
GASTROOESOPHAGEAL REFLUX DISEASE0.5% 0%
CARDIAC ARREST0.5% 0%
ANHEDONIA0.5% 0%
PLEURAL EFFUSION0.5% 0%
ELECTROCARDIOGRAM QT PROLONGED0.5% 0%
CHRONIC OBSTRUCTIVE PULMONARY DISEASE0.5% 0%
HEART RATE INCREASED0.5% 0%
BRADYCARDIA0% 0.4%
CHRONIC KIDNEY DISEASE0% 0.4%
INCORRECT DOSE ADMINISTERED0% 0.4%
HAEMOPTYSIS0.4% 0%
AMNESIA0% 0.4%
CARDIAC FAILURE0% 0.4%
ALANINE AMINOTRANSFERASE INCREASED0.4% 0%
PANCYTOPENIA0.4% 0%
JOINT SWELLING0% 0.4%

New treatments are found every day. View current Azithromycin research studies and Simvastatin clinical trials

1